| Financial Year |
March 31 2023 |
| Monetary Funds |
299,050,069.41 |
| Held-for-trading Financial Assets |
183,543,641.09 |
| Notes Receivable |
-- |
| Accounts Receivable |
873,586,185.58 |
| Advances to Suppliers |
29,490,782.88 |
| Other Receivables |
60,877,304.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,176,051,460.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
61,641,671.10 |
| Total Current Assets |
2,684,241,115.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,617,497,370.89 |
| Investment Properties |
91,991,167.32 |
| Fixed Assetes |
117,602,076.03 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,688,489.64 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
44,005,795.19 |
| Deferred Income Tax Assets |
131,248,681.70 |
| Other Non-Current Assets |
1,649,288.65 |
| Sub-Total of Non-Current Assets |
5,289,398,661.27 |
| Total Assets |
7,973,639,776.61 |
| Short-Term Loans |
909,441,651.08 |
| Trading Financial liabilities |
-- |
| Notes Payable |
149,940,000.00 |
| Accounts Payable |
254,333,777.85 |
| Accounts Received In Advance |
3,483,654.96 |
| Employee Compensation Payable |
513,153,289.88 |
| Taxes Payable |
134,659,219.47 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
553,694,992.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
812,664,357.91 |
| Other Current Liabilities |
84,016,224.85 |
| Sub-Total of Current Liabilities |
4,398,353,301.03 |
| Long-term Loans |
434,585,053.98 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
80,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
648,420,106.24 |
| Deferred Income Tax Liabilities |
35,964,066.84 |
| Other Non-Current Liabilities |
2,148,151.12 |
| Sub-Total of Non-Current Liabilities |
1,262,521,126.39 |
| Total Liabilities |
5,660,874,427.42 |
| Paid-In Capital(Or Share Stock) |
3,919,826,352.00 |
| Capital Surplus |
1,650,205,099.12 |
| Surplus Reserve |
607,521,052.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,141,794,991.62 |
| Minority Stockholder's Interest |
-685,758,980.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,998,524,330.03 |
| Owner's Equity（Stockholder's Equity） |
2,312,765,349.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,973,639,776.61 |
